Unione Europea - italiano - EMA (European Medicines Agency)

amgen europe b.v. - blinatumomab - linfoma di leucemia linfoblastica a cellule precursori - agenti antineoplastici - blincyto is indicated as monotherapy for the treatment of adults with cd19 positive relapsed or refractory b precursor acute lymphoblastic leukaemia (all). patients with philadelphia chromosome positive b-precursor all should have failed treatment with at least 2 tyrosine kinase inhibitors (tkis) and have no alternative treatment options. blincyto is indicated as monotherapy for the treatment of adults with philadelphia chromosome negative cd19 positive b-precursor all in first or second complete remission with minimal residual disease (mrd) greater than or equal to 0. blincyto is indicated as monotherapy for the treatment of paediatric patients aged 1 year or older with philadelphia chromosome negative cd19 positive b precursor all which is refractory or in relapse after receiving at least two prior therapies or in relapse after receiving prior allogeneic haematopoietic stem cell transplantation. blincyto is indicated as monotherapy for the treatment of paediatric patients aged 1 year or older with high-risk first relapsed philadelphia chromosome negative cd19 positive b-precursor all as part of the consolidation therapy (see section 4.

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

bayer s.p.a. - acarbosio - acarbosio

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

abiogen pharma s.p.a. - colecalciferolo - colecalciferolo

Italia - italiano - Ministero della Salute

zoetis italia s.r.l. - lincomicina cloridrato, spectinomicina solfato - lincomicina cloridrato - 56.7 milligrammo (i); spectinomicina solfato - nd, lincomicina cloridrato - 222 milligrammo (i); spectinomicina solfato - 444.7 milligrammo (i), spectinomicina solfato - 444.7 mg; lincomicina cloridrato - 222 mg, lincomicina cloridrato - 56.7 mg; spectinomicina solfato - nd, lincomicina cloridrato - 222 mg; spectinomicina solfato - 444.7 mg, spectinomicina solfato - nd ; lincomicina cloridrato - 56.7 mg - lincomycin, combinations

Italia - italiano - Ministero della Salute

wright medical technology, inc. - protesi di gomito - altre

Italia - italiano - Ministero della Salute

zimmer inc. - strumentario per chirurgia ortopedica - altro

Italia - italiano - Ministero della Salute

zimmer inc. - strumentario per chirurgia ortopedica - altro

Italia - italiano - Ministero della Salute

datascope patient monitoring mindray ds usa, inc. - strumentazione varia per supporto e monitoraggio dei parametri vitali non altrimenti classificata

Italia - italiano - Ministero della Salute

zimmer inc. - strumentario per chirurgia ortopedica - altro

Italia - italiano - Ministero della Salute

zimmer inc. - strumentario per chirurgia ortopedica - altro